Effect of Cholecalciferol on 24-hr ABPM and Vasoactive Hormones in Patients With Hypertension.
Phase of Trial: Phase IV
Latest Information Update: 28 Aug 2012
At a glance
- Drugs Colecalciferol (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 28 Aug 2012 New trial record
- 02 Aug 2012 Primary endpoint 24-hour (ambulatory) systolic blood pressure has not been met according to results published in the American Journal of Hypertension.